Navegando por Data de Publicação, começando com "2004-07-23"
Agora exibindo 1 - 2 de 2
- Resultados por página
- Opções de Ordenação
listelement.badge.dso-typeItem, A reação de Diels-Alder entre p-Benzoquinonas 1,3-Pentadienos-1-Substituídos(Universidade Federal de São Carlos, 2004-07-23) Finelli, Fernanda Gadini; Brocksom, Ursula; https://lattes.cnpq.br/6662565980382547In this dissertation, studies are described on the cycloaddition of 1-silyloxypentadiene- 1,3 and 1-acylamino-pentadiene-1,3 with alkylated para-benzoquinones. The first methodology involves cycloaddition reactions of dienes 51, 115 and 116, under catalysis and thermolysis conditions, with para-benzoquinones 37, 42 and 43.The second methodology involves the preparation of the diene in situ from the α,β-unsaturated aldehyde (80) and the amide (81) in the presence of the p-benzoquinones 37, 42 and 43.Theoretical calculations have been carried out on the frontier orbital energies, and the coefficients of the dienes and dienophiles employed in this work, and then compared with the experimental results. Cycloadduct 52 has been studied chemically with the objective of attaining the functionality of common eudesmane sesquiterpenes.listelement.badge.dso-typeItem, Desenvolvimento de métodos para determinação de metilbrometo de homatropina em produtos farmacêuticos empregando turbidimetria em fluxo e titulação condutimétrica(Universidade Federal de São Carlos, 2004-07-23) Canaes, Larissa de Souza; Fatibello Filho, Orlando; https://lattes.cnpq.br/9859737944357808Antimuscarinic compounds are drugs, which play important role on the central nervous system. The most widely used are atropine, escopolamine, homatropine and homatropine methylbromide. These drugs are utilized in several clinical situations, and, because of this, it is necessary to develop simple, fast and effective analytical procedures for the dosage of these pharmaceuticals. In this work, three procedures for the determination of homatropine methylbromide in the pharmaceuticals were described: two with turbidimetric detection, and one with condutometric detection. In the first procedure, the homatropine methylbromide (C16H21NO3.CH3Br)reacted with silicotungstic acid (H4Si(W3O10)4) forming a precipitated ([C16H21NO3.CH3]4[Si(W3O10)4](s)), which was measured at 410 nm. A volume of 125µL of the 1.0x10-3 mol L-1 silicotungstic acid solution and a sample volume of 375µL were introduced into a carrier at flow rates of 2.0 mL min-1 and 3.9 mL min-1 respectively and a tubular coiled reactor of 50 cm was used. A solution of 0.05 mol L-1 HCl was used to carry the sample and reagent solutions. The analytical curve was linear in the homatropine methylbromide concentration range from 8.1 x 10-5 to 2.2 x 10-4 mol L-1 (r=0,996), with a detection limit of 5.0 x 10-6 mol L-1 (3σB /slope). Relative standard deviations (RSD) of smaller than 1.5% were obtained for the homatropine methylbromide solutions in the concentrations of 1.08 x 10-4 and 1.62 x 10-4 mol L-1 (n=10). Recoveries ranging from 96.0 to 103.0% were obtained. This method was applied in the determination of this drug in the pharmaceuticals, with a sample throughput of 70 h-1.In the other flow injection procedure, the homatropine methylbromide (C16H21NO3.CH3Br) reacted with AgNO3 forming a precipitated AgBr(s), which was measured at 410 nm. A volume of 25µL of the 1.0x10-2 mol L-1 AgNO3 solution and a sample volume of 375µL were introduced into a carrier at flow rates of 2.0 mL min-1 and 3.9 mL min-1 respectively and a tubular coiled reactor of 50 cm was used. The analytical curve was linear in the homatropine methylbromide concentration range from 8.0 x 10-4 a 1.7 x 10-3 mol L-1 (r= 0,998), with a detection limit of 9.5 x mol L-1 10-5 (3σB /slope). Relative standard deviations (RSD) smaller than 2.0% were obtained for 1.2 x 10-3 and 1.5 x 10-3 mol L-1 homatropine methylbromide solutions (n=10). Recoveries ranging from 94.9 a 104,0% were obtained. This method was applied in the determination of this drug in the pharmaceuticals, with a sample throughput of 75 h-1. In the final condutometric procedure, 10 mL of either the sample solution or the homatropine methylbromide solution (C16H21NO3.CH3Br) was titrated with 1.0x10-3 mol L-1 AgNO3 at 200 rpm and 25°C. The LD was 1.0x10-4 mol L-1.